NUVL·670703107·US·equity·Healthcare - Biotechnology-13D/G
NUVL (NUVALENT INC) is held by 140 institutional investors as of Q1 2026. Largest holders: FMR LLC ($950.2M), BlackRock, Inc. ($494.3M), JPMORGAN CHASE & CO ($298.7M). Net institutional sentiment: Mixed.
See how NUVL's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer